Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2006-10-26

Clinical Trial Update: Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether sodium bicarbonate can prevent contrast-induced nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Norton Community Hospital | Conditions: Contrast Induced Nephropathy | Phase 2 | Status: UNKNOWN